Workflow
Earnings estimate revisions
icon
Search documents
Adobe Systems (ADBE) Q3 Earnings and Revenues Top Estimates
ZACKSยท 2025-09-11 22:21
Core Insights - Adobe Systems reported quarterly earnings of $5.31 per share, exceeding the Zacks Consensus Estimate of $5.17 per share, and up from $4.65 per share a year ago, representing an earnings surprise of +2.71% [1] - The company achieved revenues of $5.99 billion for the quarter ended August 2025, surpassing the Zacks Consensus Estimate by 1.50%, and up from $5.41 billion year-over-year [2] - Adobe has consistently surpassed consensus EPS and revenue estimates over the last four quarters [2] Earnings Performance - The earnings surprise for the previous quarter was +2.02%, with actual earnings of $5.06 per share compared to an expected $4.96 [1] - The current consensus EPS estimate for the upcoming quarter is $5.32, with projected revenues of $6.07 billion, while the estimate for the current fiscal year is $20.63 on $23.56 billion in revenues [7] Stock Performance and Outlook - Adobe shares have declined approximately 21.3% since the beginning of the year, contrasting with the S&P 500's gain of 11.1% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating expectations of underperformance in the near future [6] Industry Context - The Computer - Software industry, to which Adobe belongs, is currently ranked in the top 36% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Progress Software, another company in the same industry, is expected to report quarterly earnings of $1.30 per share, reflecting a year-over-year increase of +3.2% [9]
NCS Multistage (NCSM) Soars 10.3%: Is Further Upside Left in the Stock?
ZACKSยท 2025-09-11 17:55
Core Viewpoint - NCS Multistage (NCSM) shares experienced a significant rally, closing at $51.4, driven by notable trading volume and a 42.4% gain over the past four weeks [1][2]. Company Developments - The recent increase in NCSM's stock price is attributed to the acquisition of ResMetrics, a profitable tracer diagnostics firm with over 30% EBITDA margins, expected to contribute $4-5 million in revenues this year [2]. - This acquisition enhances NCS's presence in the United States and the Middle East, expanding its advanced reservoir diagnostics portfolio and positioning the company for sustained growth [2]. Financial Expectations - NCS Multistage is projected to report quarterly earnings of $1.17 per share, reflecting a year-over-year decline of 22%, while revenues are expected to reach $46.1 million, marking a 4.8% increase from the previous year [3]. - The consensus EPS estimate for NCSM has remained unchanged over the last 30 days, indicating that stock price movements may not continue without trends in earnings estimate revisions [4]. Industry Context - NCS Multistage is classified within the Zacks Oil and Gas - Field Services industry, where Ranger Energy (RNGR) also operates, closing 2.4% higher at $13.78, with a 4.1% return over the past month [5]. - Ranger Energy's consensus EPS estimate has increased by 46.2% over the past month to $0.38, although it represents a year-over-year decline of 2.6% [6].
What Makes Vontier (VNT) a New Buy Stock
ZACKSยท 2025-09-11 17:01
Core Viewpoint - Vontier Corporation (VNT) has been upgraded to a Zacks Rank 2 (Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][2]. Earnings Estimates and Stock Price Movement - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with near-term stock price movements [3][5]. - Institutional investors often rely on earnings estimates to determine the fair value of stocks, leading to buying or selling actions that affect stock prices [3]. Vontier's Earnings Outlook - The recent upgrade for Vontier indicates an improvement in the company's underlying business, which is expected to positively influence its stock price [4]. - For the fiscal year ending December 2025, Vontier is projected to earn $3.18 per share, with a 3.8% increase in the Zacks Consensus Estimate over the past three months [7]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [6]. - The upgrade to Zacks Rank 2 places Vontier in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [9].
Here's Why Evercore (EVR) is a Strong Growth Stock
ZACKSยท 2025-09-11 14:45
Core Insights - Zacks Premium provides various tools for investors to enhance their stock market strategies, including daily updates, access to the Zacks Rank, and Premium stock screens [1][2] Zacks Style Scores - Zacks Style Scores are indicators that help investors select stocks likely to outperform the market in the next 30 days, rated from A to F based on value, growth, and momentum [2][10] Value Score - The Value Score focuses on identifying undervalued stocks using financial ratios such as P/E, PEG, and Price/Sales to find attractive investment opportunities [3] Growth Score - The Growth Score assesses a company's financial health and future potential by analyzing projected and historical earnings, sales, and cash flow [4] Momentum Score - The Momentum Score identifies optimal times to invest based on price trends and earnings estimate changes, emphasizing the importance of market trends [5] VGM Score - The VGM Score combines the Value, Growth, and Momentum Scores to highlight stocks with the best overall potential, serving as a strong indicator alongside the Zacks Rank [6] Zacks Rank - The Zacks Rank is a proprietary model that utilizes earnings estimate revisions to guide investors in building successful portfolios, with 1 (Strong Buy) stocks achieving an average annual return of +23.64% since 1988, significantly outperforming the S&P 500 [7][8] Stock to Watch: Evercore (EVR) - Evercore Inc. is a leading independent investment banking advisory firm with a Zacks Rank of 1 (Strong Buy) and a VGM Score of B, indicating strong investment potential [12] - Evercore is particularly appealing for growth investors, with a Growth Style Score of A and a projected year-over-year earnings growth of 34.5% for the current fiscal year, alongside a Zacks Consensus Estimate increase to $12.67 per share [13]
Soleno Therapeutics (SLNO) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ZACKSยท 2025-09-11 14:36
A downtrend has been apparent in Soleno Therapeutics, Inc. (SLNO) lately with too much selling pressure. The stock has declined 26% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock i ...
Strength Seen in Travere (TVTX): Can Its 26.2% Jump Turn into More Strength?
ZACKSยท 2025-09-11 10:01
Company Overview - Travere Therapeutics (TVTX) shares increased by 26.2% to close at $27.31, with trading volume significantly higher than usual, and a 24.3% gain over the past four weeks [1][2] Drug Development and FDA Approval - The surge in Travere's stock was driven by the FDA's announcement that no advisory committee review is needed for its Filspari supplemental new drug application for focal segmental glomerulosclerosis, with a decision expected in January 2026 [2] - If approved, Filspari would be the first treatment specifically for this rare kidney disease, supported by strong clinical data indicating significant proteinuria reduction and lower kidney failure risk [2] - Filspari is already approved for IgA nephropathy and has recently gained a streamlined safety program, enhancing its potential for adoption [2] Financial Performance Expectations - Travere is projected to report a quarterly loss of $0.32 per share, reflecting a year-over-year increase of 54.3%, with expected revenues of $102.15 million, up 62.4% from the same quarter last year [3] - The consensus EPS estimate for the quarter has been revised marginally lower over the last 30 days, indicating a negative trend in earnings estimate revisions, which typically does not lead to price appreciation [4] Industry Context - Travere operates within the Zacks Medical - Biomedical and Genetics industry, where another company, Regeneron (REGN), closed at $555.83, showing a slight decline of 0.1% in the last trading session [4] - Regeneron's consensus EPS estimate has decreased by 0.8% over the past month to $9.46, representing a 24.1% decline from the previous year [5]
Will Ciena (CIEN) Gain on Rising Earnings Estimates?
ZACKSยท 2025-09-10 17:21
Core Viewpoint - Ciena (CIEN) shows a favorable earnings outlook with analysts raising their earnings estimates, indicating potential for continued stock performance [1][2]. Earnings Estimate Revisions - The upward trend in earnings estimate revisions reflects growing analyst optimism about Ciena's earnings prospects, which is expected to positively impact its stock price [2]. - The current-quarter earnings estimate is $0.74 per share, representing a 37.0% increase from the previous year, with a 17.81% rise in the Zacks Consensus Estimate over the last 30 days [6]. - For the full year, Ciena is projected to earn $2.43 per share, a year-over-year increase of 33.5%, with six estimates moving higher recently [7]. Zacks Rank and Performance - Ciena has achieved a Zacks Rank 1 (Strong Buy) due to strong agreement among analysts in revising earnings estimates upward, which historically correlates with stock outperformance [3][8]. - Stocks with Zacks Rank 1 and 2 have shown significant outperformance compared to the S&P 500 [8]. Recent Stock Performance - Ciena shares have increased by 26.8% over the past four weeks, indicating investor confidence in the company's earnings growth prospects [9].
All You Need to Know About SGS (SGSOY) Rating Upgrade to Buy
ZACKSยท 2025-09-10 17:01
Core Viewpoint - SGS SA (SGSOY) has been upgraded to a Zacks Rank 2 (Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][2]. Earnings Estimates and Stock Price Impact - Changes in a company's future earnings potential, as indicated by earnings estimate revisions, are strongly correlated with near-term stock price movements [3]. - Institutional investors utilize earnings estimates to determine the fair value of a company's shares, leading to stock price movements based on their buying or selling activities [3]. SGS Earnings Outlook - The rising earnings estimates for SGS indicate an improvement in the company's underlying business, which is expected to positively influence its stock price [4]. - Analysts have increased their earnings estimates for SGS, with the Zacks Consensus Estimate rising by 2.2% over the past three months [7]. Zacks Rank System - The Zacks Rank stock-rating system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have generated an average annual return of +25% since 1988 [6]. - The upgrade of SGS to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [9].
Datadog (DDOG) Just Overtook the 50-Day Moving Average
ZACKSยท 2025-09-10 14:31
Group 1 - Datadog (DDOG) has reached a significant support level and recently broke through the 50-day moving average, indicating a short-term bullish trend [1] - Shares of DDOG have increased by 8.9% over the past four weeks, and the company holds a Zacks Rank 3 (Hold), suggesting potential for continued growth [2] - There have been 13 positive earnings estimate revisions for the current fiscal year, with no downward revisions, indicating strong bullish sentiment [2][3] Group 2 - The combination of positive earnings estimate revisions and the technical breakout at a key level positions DDOG as a stock to watch for potential gains in the near future [3]
Buy the Dip in These Top Financial Management Stocks: AAMI, AB
ZACKSยท 2025-09-05 17:06
Core Insights - September is typically a weak month for the stock market, but it presents opportunities for investors willing to take on risk, particularly in Acadian Asset Management and AllianceBernstein, which have recently dipped below their 52-week highs [1][2] Financial Performance - Acadian Asset Management reported a record AUM of $151.1 billion, while AllianceBernstein reached an all-time high AUM of $829 billion, driven by strong global equity inflows [5] - Acadian's EPS estimates for fiscal years 2025 and 2026 have increased by 17% and 26%, respectively, with an expected annual earnings surge of 35% this year and a projected 21% increase in FY26 to $4.50 per share [6][7] - AllianceBernstein's FY25 EPS estimates have risen by 4% in the last two months, with FY26 revisions up by 7%, forecasting a 2% expansion in FY25 and an 11% increase next year to $3.69 per share [7] Valuation Metrics - Both Acadian and AllianceBernstein are trading at forward P/E multiples of 11X, significantly lower than the broader Zacks finance sector's 19X and the S&P 500's 24X, indicating attractive valuation [8] Investment Outlook - Acadian Asset Management holds a Zacks Rank 1 (Strong Buy) and is expected to rebound from its 52-week high of $51 per share, while AllianceBernstein has a Zacks Rank 2 (Buy) and is projected to return to its one-year peak of $43 per share, offering a 7.71% annual dividend yield [11]